Following adults with primary hyperparathyroidism over time after parathyroid surgery
Follows adults with primary hyperparathyroidism to see how surgery affects their health.
Key facts
- Who runs it
- Nantes University Hospital
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Cohort Primary Hyperparathyroidism
- Status
- Recruiting
- People taking part
- 403 people, planned
- Started
- 31 Mar 2016
- Expected to end
- 24 Feb 2027
- Type of study
- Observational
- Record updated
- 8 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults diagnosed with primary hyperparathyroidism at Nantes University Hospital. It follows how they do after surgery to remove the parathyroid glands (parathyroidectomy).
- Age
- Over 18 years
- Sex
- All sexes
- Disease stage
- Primary hyperparathyroidism (overactive parathyroid glands not caused by another condition)
Main reasons for not taking part
- Under 18 years old
- Pregnant or breastfeeding
- Adults under legal guardianship
- Secondary or tertiary hyperparathyroidism
- Multiple endocrine neoplasia (an inherited condition causing tumours in hormone glands)
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age > 18
Who cannot take part
- Age < 18
- Pregnancy / lactation
- Adults underguardianship
- Secondary/tertiary hyperparathyroidism
- Multiple endocrine neoplasia
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
CoHPT is a prospective, monocentric, observational cohort including all patients diagnosed with primary hyperparathyroidism in Nantes University Hospital, aiming to study the outcomes associated with parathyroidectomy. Clinical and biochemical evaluation is performed at the inclusion, and 6, 12, 36 and 60 months. A biocollection is collected. The main hypotheses are that parathyroidectomy could improve cardiovascular, renal, bone, and cardiovascular outcomes along with quality of life.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective Cohort Primary Hyperparathyroidism
- Plain-language title
- Following adults with primary hyperparathyroidism over time after parathyroid surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Publications
- Radius Bone Mineral Density Measurement Is Essential During Initial PHPT Workup: Results of a Retrospective Study on 400 Patients.World journal of surgery, 2026
- Parathyroidectomy for primary hyperparathyroidism: effect on quality of life after 3 years - a prospective cohort study.International journal of surgery (London, England), 2023
- Record updated
- 8 September 2025